Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine Effects on Myocardial Perfusion
NCT01221272Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of ranolazine in Myocardial ischemia (MI), sponsored by Gilead Sciences. Started Sep 2010; status: completed.
02
Drugs
ranolazine
03
Conditions
Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT01221272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221272.